Querying ClinicalTrials.gov
Every result is fetched from the registry at the moment you ask, so this takes a few seconds. Nothing here is a cached list.
Eligibility map · free · live registry data
Interventional trials and expanded-access programs, queried live from ClinicalTrials.gov against the profile you enter. Each published criterion comes back as matched, not matched, or honestly unknown — never guessed. Only the trial site can determine actual eligibility.
NCT06203821 · Aram Hezel
NP137
Site
Not medical advice. Trial0 is a navigation service, not a medical provider. Nothing here is medical advice or a recommendation to pursue any treatment; eligibility matching is informational, based on published registry criteria, and only the trial site or treating clinician can determine actual eligibility. Decisions belong with the patient and their own doctors. Results come from Trial0’s live query of ClinicalTrials.gov and reflect what the registry publishes right now.
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT07802184 · West China Hospital
SHR-1701 · Apatinib · gemcitabine · Nab-paclitaxel
Site
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT06782932 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
AGEN2373 · Balstilimab · Cyclophosphamide · GVAX
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07665684 · University Health Network, Toronto
Samuraciclib + Gemcitabine & Nab-Paclitaxel
Site
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT06959615 · Jacobio Pharmaceuticals Co., Ltd.
JAB-23E73 · JAB-23E73
3 of 32 sites
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT05802485 · Institut Paoli-Calmettes
collection of blood and tumor samples
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT04575363 · CHU de Reims
Blood sample
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07814326 · Urban Arnelo
Loop Brush Fine Needle Aspiration
Site
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT07238283 · Jiangsu HengRui Medicine Co., Ltd.
Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate · nab-paclitaxel; gemcitabine
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT06479239 · University of Virginia
EGFR FPBMC
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07821554 · Inna Chen, MD
Experimental: Personalised nutritional care delivered by a trained dietitian
3 of 5 sites
MatchedStudy open to new participants
Registry overall status: NOT_YET_RECRUITING
NCT06695845 · Jazz Pharmaceuticals
Zanidatamab
3 of 28 sites
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT06411795 · Masonic Cancer Center, University of Minnesota
Bupivacaine · Hydromorphone · Iopamidol · Liposomal Bupivacaine
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT04969731 · GC Cell Corporation
Immuncell-LC · Gemcitabine
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT06580002 · University of California, Irvine
Riluzole · Placebo
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07360119 · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Total Pancreatectomy with Islet Autotransplantation (TPIAT)
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT05365581 · Astellas Pharma Global Development, Inc.
ASP2138 · Pembrolizumab · Oxaliplatin · Leucovorin
3 of 46 sites
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT03556228 · VM Oncology, LLC
VMD-928 100 mg Tablet · VMD-928 Tablet and Pembrolizumab (200 mg)
3 of 15 sites
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07716228 · Second Affiliated Hospital, Zhejiang University, School of Medicine
Auricular point stimulation plus dexamethasone · Standard pharmacologic antiemetic regimen
Site
MatchedStudy open to new participants
Registry overall status: RECRUITING
NCT07671339 · Memorial Sloan Kettering Cancer Center
ELI-002 7P · Tislelizumab · mFOLFIRINOX
3 of 7 sites
MatchedStudy open to new participants
Registry overall status: RECRUITING